(4'-[(1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid

CAS: 1026353-20-7

Ref. 3D-ID31884

Produktinformation

• Name: (4'-[(1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid
• Synonyme: Telmisartan impurity B, [1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,7'-dimethyl-2'-propyl[2,5'-bi-1H-benzimidazol]-1'-yl)methyl]-, 2-[4-[[7-Methyl-5-(1-Methylbenzimidazol-2-Yl)-2-Propylbenzimidazol-1-Yl]Methyl]Phenyl]Benzoic Acid, Unii-3178N39Y2I, Telmisartan related compound B RS [USP], Telmisartan related compound B [USP], 4'-[(1,7'-Dimethyl-2'-propyl[2,5'-bi-1H-benzimidazol]-1'-yl)methyl][1,1'-biphenyl]-2-carboxylic Acid, Telmisartan related compound B, Telmisartan specified impurity B [EP], Bip036

Beschreibung

4-Biphenylcarboxylic acid is a natural metabolite of the drug bibenzonium, an antipsychotic agent. It can also be obtained by synthesis from 4-biphenylacetic acid. 4'-[(1,7'-Dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl]biphenyl-2-carboxylic acid can be used as a research and development standard for HPLC. This compound has been shown to inhibit CYP3A4 and CYP2D6 liver enzymes and may impair the metabolism of other drugs.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 514.62 g/mol
• Formel: C₃₃H₃₀N₄O₂
• Reinheit: (%) Min. 97%
• Farbe/Form: Powder
• InChl: InChI=1S/C33H30N4O2/c1-4-9-30-34-28-19-24(32-35-27-12-7-8-13-29(27)36(32)3)18-21(2)31(28)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
• InChI Key: InChIKey=COYNILPBALLLCR-UHFFFAOYSA-N
• SMILES: CCCc1nc2cc(-c3nc4ccccc4n3C)cc(C)c2n1Cc1ccc(-c2ccccc2C(=O)O)cc1